| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2016 | Jul 20, 2016 | ARDELYX, INC. | 10% Owner | Buy | 96.3 | +763,650 | 9.56% | ✗ | $6.7M |
| Jan 13, 2016 | Jan 14, 2016 | ARDELYX, INC. | 10% Owner | Buy | 96.3 | +500,000 | 6.68% | ✗ | $5M |
| Jun 5, 2015 | Jun 9, 2015 | ARDELYX, INC. | 10% Owner | Buy | 100.0 | +1,869,159 | 33.26% | ✗ | $20M |
| Aug 27, 2014 | Aug 29, 2014 | Viracta Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -266,700 | -5.41% | ✗ | $2.1M |
| Aug 8, 2014 | Aug 12, 2014 | Viracta Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -710,540 | -12.61% | ✗ | $4.7M |
| Jun 30, 2010 | Jul 2, 2010 | Viracta Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +23,824,451 | 100.00% | ✗ | $6.6M |